Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, PT Sukses Sejati received an FDA Warning Letter on January 9, 2018, though the specific subject matter and detailed violations are not available in the provided information. The letter pertains to a product categorized as "Other," indicating it falls outside standard FDA product categories such as drugs, devices, or food. Without access to the full warning letter text or the issuing office details, the specific nature of the regulatory violations and the particular product involved cannot be determined from this metadata alone.